Maxalt and Sumavel dosepro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxalt (rizatriptan benzoate) and Sumavel dosepro (sumatriptan succinate). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Maxalt and Sumavel dosepro. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.

What is Sumavel dosepro?

Sumavel dosepro has active ingredients of sumatriptan succinate. eHealthMe is studying from 1,276 Sumavel dosepro users. Check the latest studies of Sumavel dosepro.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

25 people who take Maxalt and Sumavel dosepro together, and have interactions are studied.

Maxalt and Sumavel dosepro drug interactions.

What are the common drug interactions of Maxalt and Sumavel Dosepro, by gender? *:

female:

Drug ineffective
Injection site pain
Lymphoma (cancer that begins in immune system cells)
Oesophageal dysplasia (abnormality of oesophagus development)
Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
Somnolence (a state of near-sleep, a strong desire for sleep)
Throat tightness
Headache (pain in head)
Anxiety
Hypotension (abnormally low blood pressure)

male:

n/a

What are the common drug interactions of Maxalt and Sumavel Dosepro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug ineffective
Drug effect decreased
Injection site erythema (redness at injection site)
Injection site mass
Injection site swelling

30-39:

Drug ineffective
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Vomiting
Muscle tightness
Neck pain
Pain in jaw

40-49:

Injection site pain
Alopecia (absence of hair from areas of the body)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anxiety
Arthralgia (joint pain)
Asthenia (weakness)
Chest discomfort
Chest pain
Constipation
Dyspnoea (difficult or laboured respiration)

50-59:

Asthenia (weakness)
Blood pressure immeasurable
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Hypoaesthesia (reduced sense of touch or sensation)
Throat tightness
Injection site haemorrhage (bleeding from injection site)
Injection site pain
Hypotension (abnormally low blood pressure)
Somnolence (a state of near-sleep, a strong desire for sleep)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 20.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 16.00%
Headache (pain in head): 3 people, 12.00%
Thyroid Diseases: 2 people, 8.00%
Nausea (feeling of having an urge to vomit): 2 people, 8.00%
Menopause (end of monthly cycles in women): 2 people, 8.00%
Depression: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt and Sumavel dosepro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously